Chesapeake Clinical Research Inc

Clinical research site in Baltimore, Maryland

As of July 2026, 1 paid clinical trial is recruiting at Chesapeake Clinical Research Inc in Baltimore, Maryland. Active studies at this site focus on Chronic Spontaneous Urticaria (CSU) alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Chesapeake Clinical Research Inc (1)

A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines

for Chronic Spontaneous Urticaria (CSU)

128 locations incl. Birmingham

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06868212·Phase 3·Recruiting·Listed Mar 2025

Apply to this trial

More research sites in Baltimore

Johns Hopkins University (185 trials)
Johns Hopkins Hospital (119 trials)
Johns Hopkins University/Sidney Kimmel Cancer Center (64 trials)
University of Maryland (59 trials)
University of Maryland Medical Center (52 trials)
Sinai Hospital of Baltimore (50 trials)
University of Maryland/Greenebaum Cancer Center (47 trials)
Johns Hopkins University School of Medicine (44 trials)
Johns Hopkins (38 trials)
Kennedy Krieger Institute (32 trials)

Explore more

Paid clinical trials in Baltimore, MD · Maryland clinical trials